Aziyo Biologics, Inc. (AZYO) Misses Q2 EPS by 13c

Aziyo Biologics, Inc. (NASDAQ: AZYO) reported Q2 EPS of ($0.69), $0.13 worse than the analyst estimate of ($0.56). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $11.59 million.

For earnings history and earnings-related data on Aziyo Biologics, Inc. (AZYO) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does